EGM Statement

RNS Number:5327I
Interactivity Group PLC
10 March 2003

Interactivity Group plc

The directors of Interactivity Group plc ("Interactivity" or "the Company")
announce that, at the Company's Extraordinary General meeting held this morning,
all the resolutions necessary to effect the acquisition of L&P - MCC, Inc. 
("L&P") were passed, including the approval of the Rule 9 whitewash and the 
change in the name of the Company to Healthcare Enterprise Group PLC.

The Company will continue to be traded as Interactivity Group PLC on AIM
tomorrow and is expected to change to Healthcare Enterprise Group PLC, with the
Stock Exchange symbol, "HEGA", on Wednesday 12 March 2003.

Application has been made for the new ordinary shares being issued pursuant to
the acquisition to be admitted to trading on AIM and dealings are expected to
commence tomorrow, 11 March 2003.

At admission, the concert party (details of whom were set out in the admission
document issued in connection with the acquisition of L&P, dated 14 February
2003 ("Admission Document")) will own an aggregate of 1,180,723,605 ordinary
shares, representing 86.0 per cent. of the share capital and will hold options
to subscribe for a further 228,387,172 ordinary shares.  These options become
capable of exercise in tranches and therefore the maximum shareholding of the
concert party of 1,409,110,777 ordinary shares, representing a maximum of 88.0
per cent. of the issued ordinary share capital of the Company, cannot be held by
the concert party until 15 January 2006.

In addition, at admission, Medical Investment Group Holdings Limited and
European Life Science Investors Limited will together hold 452,983,861 ordinary
shares, representing 33.0 per cent. of the share capital.

The Company's registered office is being changed to Aurora House, 5-6 Carlos
Place London W1K 3AP and its accounting reference date to 28 February.  
Accordingly the Company proposes to publish accounts for the five months ended 
28 February 2003.

The current directors of Interactivity (being Christopher Akers, Rodger Sargent
and Graham Perske) will resign upon admission and the following will be
appointed as directors, also with effect from admission:

Stuart Bruck, Executive Chairman
Michael Low, Chief Operating Officer
Lyndon Gaborit, Finance Director and Company Secretary
Nicholas Brigstocke, Non-Executive Director
Anthony Moore, Non-Executive Director
Mark Tompkins, Non-Executive Director

Details of the proposed directors were set out in the Admission Document.

Commenting, Stuart Bruck said "I am delighted that we have achieved our goal of
listing our company on AIM and look forward to building Healthcare Enterprise
Group into a substantial global business".

Contact details:

Stuart Bruck (via Michelle James/Wriglesworth Consultancy: 07958 451446)


                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

EGMJMMFTMMTBBLJ